Keep up with market dynamics and successively attend international congresses after the pandemic

Author:Aurora Date:2022-05-10


 

Jafron, as a global supplier of hemoperfusion cartridges, attended major medical exhibitions after the pandemic: AKI&CRRT and ISICEM Exhibitions.

 

Jafron in the AKI&CRRT Exhibition

AKI&CRRT 2022, held in San Diego from March 7 -10, aims to provide participants with the knowledge and understanding to utilize CRRT to manage critically ill patients. 


image


This is Jafron's first time participating in AKI&CRRT after the pandemic. Attending by the native team, Jafron has brought hemoperfusion products and the latest news to doctors in North America and Latin America. With 20 years of clinical practice in blood purification, Jafron provides adsorption therapy with several types of hemoperfusion cartridges. Such as HA130 for ESRD patients, HA230 for acute poisoning, and HA380 for critical illnesses. These disposable hemoperfusion cartridges have been used in more than 80 countries, and more than 5 million applications are performed each year globally.

 

About ISICEM Exhibition

The 41st ISICEM during March 22-25, 2022 provides participants with the latest advances clinical research.


image


Jafron attended the ISICEM Exhibition with the theme of Master the acute phase, and the local team brought the flagship product HA series cartridges and the newly launched adsorption device F20.

 

According to the clinical data, HA380, which eliminates inflammatory mediators and cytokines, can be applied in acute pancreatitis, sepsis, septic shock, and other conditions. It provides a solution to control the inflammatory cytokine storm, improve hemodynamics, and prevent further organ damage and complications.

 

Another eye-catching product at the congress, the Future F20, is a professional platform supporting multiple adsorption therapies, which provides an innovative blood purification system with high flexibility in hemoperfusion and plasma adsorption.

image

Conclusion

As a global supplier in the blood purification industry, Jafron is committed to serving  patients with the family of high-quality adsorption therapies. To establish close connections with more patients, healthcare providers, and partners, Jafron will bring a full range of hemoadsorption products and new equipment to the ERA in Paris in May and the Vicenza Course in June. You are welcome to visit Jafron onsite to join activities and the satellite symposium for more information.